Skip to main content
. 2023 Jan 24;23(1):1–244.

Table 51:

Budget Impact Analysis Results for Adults Hospitalized Due to Acute Deep Vein Thrombosis, Sensitivity Analyses

Scenario Budget impact, in millions (2022 CAD)a,b,c
Year 1 Year 2 Year 3 Year 4 Year 5 Total
Reference case
Budget impact 0.77 0.93 1.10 1.27 1.44 5.52
1. Including only the costs of disposable devices for MT
Budget impact 0.39 0.47 0.56 0.65 0.74 2.82
2. Considering MT only as the alternative of CDT
Budget impact -0.11 -0.13 -0.14 -0.16 -0.18 -0.72
3. Target population 20% larger than the reference case
Budget impact 0.92 1.12 1.32 1.53 1.73 6.62
4. Costs of disposable devices 25% lower than the reference case
Budget impact 0.67 0.82 0.96 1.11 1.26 4.81
5-1. Cost savings of ICU and ward stay of MT treatment 25% higher than the reference case
Budget impact 0.60 0.74 0.88 1.01 1.15 4.39
5-2. Cost savings of ICU and ward stay of MT treatment 25% lower than the reference case
Budget impact 0.93 1.13 1.33 1.53 1.74 6.65

Abbreviations: CDT, catheter-directed treatment; DVT, deep vein thrombosis; ICU, Intensive care unit; MT, mechanical thrombectomy.

a

Negative costs indicate savings.

b

Some numbers may appear inexact due to rounding.

c

If a hospital purchases equipment for MT, the equipment can be used for both populations—arterial acute limb ischemia and acute DVT. Since we included the scenario of additional purchases of equipment for MT treatment in next 5 years in the sensitivity analysis of arterial acute limb ischemia (Table 50), we did not include it in this table.